Previous 10 | Next 10 |
When a stock nearly triples in its first year as a public company, people tend to notice. That was the case with Inari Medical (NASDAQ: NARI) . The company went from one analyst covering it last year to six -- all but one with a buy rating -- heading into its first quarter earnings ...
Executives and analysts often do a bit of a dance on the conference calls after a company reports earnings. Management wants to highlight everything that is going well and analysts are focused on what numbers to punch into their spreadsheets. If there are surprising numbers, management ofte...
Shares of Inari Medical (NASDAQ: NARI) were down almost 16% as of 11:25 a.m. EDT today, after the company reported earnings yesterday that seemed impressive at first glance. After digging a little deeper, Wall Street found a few concerns. The company's clot removal devic...
Gainers: CohBar (NASDAQ:CWBR) +42%, Allied Healthcare Products AHPI +24%, Doximity DOCS +22%, Orphazyme (NASDAQ:ORPH) +13%, Fulcrum Therapeutics FULC +13%. Losers: Biodesix (NASDAQ:BDSX) -19%, Inari Medical (NASDAQ:NARI) -16%, Berkeley Li...
Most financial news isn't created with the purpose of producing good investment decisions. It is designed to provide information in an engaging way while creating a constant sense of needing to act. This year offers plenty of examples. The latest is the recent initial public offering of R...
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q2 2021 Earnings Call Aug 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q2 2021 Earnings Call Transcript
Inari Medical, Inc. (NARI) Q2 2021 Earnings Conference Call August 10, 2021 04:30 PM ET Company Participants Caroline Corner - Investor Relations Bill Hoffman - President & Chief Executive Officer Mitch Hill - Chief Financial Officer Drew Hykes - Chief Operating Officer Tom Tu - Chief Med...
IRVINE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial results...
The shares of medical device makers have come under pressure in morning hours after Texas Governor Greg Abbott encouraged the hospitals to consider postponing certain elective medical procedures to make room for rising COVID-19 patients in the state. The seven-day average of COVID-19 hospital...
Inari Medical (NASDAQ: NARI) went public in what should have been one of the most difficult times for a non-COVID related healthcare company ever -- May 2020. Yet it has ridden the success of its clot-removing devices -- the FlowTriever and ClotTriever -- to 124% gains since. ...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...